Guo Y - Search Results

1

Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma.

Chen Z, Xu L, Su T, Ke Z, Peng Z, Zhang N, Peng S, Zhang Q, Liu G, Wei G, Guo Y, He M, Kuang M. Chen Z, et al. Among authors: guo y. Biochem Biophys Res Commun. 2017 Nov 4;493(1):365-372. doi: 10.1016/j.bbrc.2017.09.016. Epub 2017 Sep 5. Biochem Biophys Res Commun. 2017. PMID: 28887036

2

Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma.

Guo Y, Liang X, Lu M, Weng T, Liu Y, Ye X. Guo Y, et al. Hepatogastroenterology. 2010 Jul-Aug;57(101):913-8. Hepatogastroenterology. 2010. PMID: 21033251

3

βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway.

Ye X, Guo Y, Zhang Q, Chen W, Hua X, Liu W, Yang Y, Chen G. Ye X, et al. Among authors: guo y. PLoS One. 2013;8(1):e55615. doi: 10.1371/journal.pone.0055615. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383245 Free PMC article.

4

Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.

Guo Y, Wang J, Li H, Liu W, Chen D, Zhao K, Liang X, Zhang Q, Yang Y, Chen G. Guo Y, et al. J Gastroenterol Hepatol. 2015 Jun;30(6):1094-103. doi: 10.1111/jgh.12923. J Gastroenterol Hepatol. 2015. PMID: 25684393

5

Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy.

Guo Y, Wu Z, Shen S, Guo R, Wang J, Wang W, Zhao K, Kuang M, Shuai X. Guo Y, et al. Among authors: guo r. Nat Commun. 2018 Aug 24;9(1):3430. doi: 10.1038/s41467-018-05764-7. Nat Commun. 2018. PMID: 30143633 Free PMC article.

6

Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.

Ji F, Zhang Y, Zhu ZB, Guo Y, Shen SL, Cao QH, Li SQ, Peng BG, Liang LJ, Hua YP. Ji F, et al. Among authors: guo y. Hum Pathol. 2019 Apr;86:193-202. doi: 10.1016/j.humpath.2018.11.025. Epub 2018 Dec 8. Hum Pathol. 2019. PMID: 30529751

7

Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy.

Xiao H, Chen ZB, Jin HL, Li B, Xu LX, Guo Y, Chen SL, Li HP, Peng ZW, Shen JX. Xiao H, et al. Among authors: guo y. Am J Transl Res. 2019 Mar 15;11(3):1864-1875. eCollection 2019. Am J Transl Res. 2019. PMID: 30972210 Free PMC article.

8

Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.

Wu SS, Shan QY, Xie WX, Chen B, Huang Y, Guo Y, Xie XY, Lu MD, Peng BG, Kuang M, Shen SL, Wang W. Wu SS, et al. Among authors: guo y. Clin Transl Oncol. 2020 Mar;22(3):401-410. doi: 10.1007/s12094-019-02141-8. Epub 2019 Jun 6. Clin Transl Oncol. 2020. PMID: 31172445

9

Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner.

Tan L, Chen S, Wei G, Li Y, Liao J, Jin H, Zou Y, Huang M, Peng Z, Guo Y, Peng S, Xu L, Kuang M. Tan L, et al. Among authors: guo y. Cancer Lett. 2019 Sep 28;460:29-40. doi: 10.1016/j.canlet.2019.05.041. Epub 2019 Jun 4. Cancer Lett. 2019. PMID: 31173855

10

Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.

Li Q, Ma L, Shen S, Guo Y, Cao Q, Cai X, Feng J, Yan Y, Hu T, Luo S, Zhou L, Peng B, Yang Z, Hua Y. Li Q, et al. Among authors: guo y. J Exp Clin Cancer Res. 2019 Jul 11;38(1):303. doi: 10.1186/s13046-019-1271-3. J Exp Clin Cancer Res. 2019. PMID: 31296243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,747 results

Search Page

Filters